114 related articles for article (PubMed ID: 17047384)
1. Positron emission tomography in acromegaly and other pituitary adenoma patients.
Muhr C
Neuroendocrinology; 2006; 83(3-4):205-10. PubMed ID: 17047384
[TBL] [Abstract][Full Text] [Related]
2. In vivo measurement of dopamine receptors in pituitary adenomas using positron emission tomography.
Muhr C; Bergström M; Lundberg PO; Bergström K; Långström B
Acta Radiol Suppl; 1986; 369():406-8. PubMed ID: 2980511
[TBL] [Abstract][Full Text] [Related]
3. PET as a tool in the clinical evaluation of pituitary adenomas.
Bergström M; Muhr C; Lundberg PO; Långström B
J Nucl Med; 1991 Apr; 32(4):610-5. PubMed ID: 2013801
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT.
Pirker W; Riedl M; Luger A; Czech T; Rössler K; Asenbaum S; Angelberger P; Kornhuber J; Deecke L; Podreka I; Brücke T
J Nucl Med; 1996 Dec; 37(12):1931-7. PubMed ID: 8970508
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of pituitary adenoma and meningioma: visualization with positron emission tomography and [11C]-L-deprenyl.
Bergström M; Muhr C; Jossan S; Lilja A; Nyberg G; Långström B
Neurosurgery; 1992 Jun; 30(6):855-61. PubMed ID: 1614586
[TBL] [Abstract][Full Text] [Related]
6. Clinical usefulness of coregistered 11C-methionine positron emission tomography/3-T magnetic resonance imaging at the follow-up of acromegaly.
Rodriguez-Barcelo S; Gutierrez-Cardo A; Dominguez-Paez M; Medina-Imbroda J; Romero-Moreno L; Arraez-Sanchez M
World Neurosurg; 2014; 82(3-4):468-73. PubMed ID: 24239736
[TBL] [Abstract][Full Text] [Related]
7. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptors in pituitary adenomas: PET visualization with 11C-N-methylspiperone.
Muhr C; Bergström M; Lundberg PO; Bergström K; Hartvig P; Lundqvist H; Antoni G; Långström B
J Comput Assist Tomogr; 1986; 10(2):175-80. PubMed ID: 3485123
[TBL] [Abstract][Full Text] [Related]
9. [Clinical application of 11C-NMSP to the patients with pituitary adenoma other than prolactinoma].
Momose T; Teramoto A; Nishikawa J; Inoue Y; Watanabe T; Sasaki Y
Kaku Igaku; 1993 Jun; 30(6):627-35. PubMed ID: 8345693
[TBL] [Abstract][Full Text] [Related]
10. Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study.
Bergström M; Muhr C; Lundberg PO; Bergström K; Gee AD; Fasth KJ; Långström B
J Comput Assist Tomogr; 1987; 11(5):815-9. PubMed ID: 3498743
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic imaging of dopamine receptors in pituitary adenomas.
de Herder WW; Reijs AEM; Feelders RA; van Aken MO; Krenning EP; van der Lely AJ; Kwekkeboom DJ
Eur J Endocrinol; 2007 Apr; 156 Suppl 1():S53-S56. PubMed ID: 17413189
[TBL] [Abstract][Full Text] [Related]
12. Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas.
Ferone D; Lastoria S; Colao A; Varrella P; Cerbone G; Acampa W; Merola B; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 1998 Jan; 83(1):248-52. PubMed ID: 9435450
[TBL] [Abstract][Full Text] [Related]
13. Amino acid metabolism in pituitary adenomas.
Bergström M; Muhr C; Lundberg PO; Bergström K; Lundqvist H; Långström B
Acta Radiol Suppl; 1986; 369():412-4. PubMed ID: 2980512
[TBL] [Abstract][Full Text] [Related]
14. Striatal and extrastriatal dopamine D2 receptor occupancy by a novel antipsychotic, blonanserin: a PET study with [11C]raclopride and [11C]FLB 457 in schizophrenia.
Tateno A; Arakawa R; Okumura M; Fukuta H; Honjo K; Ishihara K; Nakamura H; Kumita S; Okubo Y
J Clin Psychopharmacol; 2013 Apr; 33(2):162-9. PubMed ID: 23422369
[TBL] [Abstract][Full Text] [Related]
15. Amino acid distribution and metabolism in pituitary adenomas using positron emission tomography with D-[11C]methionine and L-[11C]methionine.
Bergström M; Muhr C; Lundberg PO; Bergström K; Lundqvist H; Antoni G; Fasth KJ; Långström B
J Comput Assist Tomogr; 1987; 11(3):384-9. PubMed ID: 3494753
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of dopamine D2 receptors in human pituitary adenomas.
Pawlikowski M
Folia Histochem Cytobiol; 2010 Sep; 48(3):394-7. PubMed ID: 21071344
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography of pituitary macroadenomas: hormone production and effects of therapies.
Francavilla TL; Miletich RS; DeMichele D; Patronas NJ; Oldfield EH; Weintraub BD; Di Chiro G
Neurosurgery; 1991 Jun; 28(6):826-33. PubMed ID: 2067604
[TBL] [Abstract][Full Text] [Related]
18. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
Suzuki M; Hatano K; Sakiyama Y; Kawasumi Y; Kato T; Ito K
Synapse; 2001 Sep; 41(4):285-93. PubMed ID: 11494399
[TBL] [Abstract][Full Text] [Related]
19. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography applied in the study of pituitary adenomas.
Muhr C; Bergström M
J Endocrinol Invest; 1991 Jun; 14(6):509-28. PubMed ID: 1837798
[No Abstract] [Full Text] [Related]
[Next] [New Search]
